Medistim ASA reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was NOK 141.82 million compared to NOK 112.74 million a year ago. Revenue was NOK 141.82 million compared to NOK 112.74 million a year ago.

Net income was NOK 32.48 million compared to NOK 16.11 million a year ago. Basic earnings per share from continuing operations was NOK 1.78 compared to NOK 0.88 a year ago. Diluted earnings per share from continuing operations was NOK 1.78 compared to NOK 0.88 a year ago.